Gyeonggi-do, South Korea

Youn Jae Shin

This inventor holds 1 USPTO granted patent and 3 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Taejoon Pharmaceutical Co., Ltd.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Youn Jae Shin. Retrieved from https://idiyas.com/inventor/youn-jae-shin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Youn Jae Shin: Innovator in Ophthalmic Solutions

Introduction

Youn Jae Shin is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of ophthalmology, particularly in developing solutions for managing intraocular pressure.

Latest Patents

Youn Jae Shin holds a patent for an ophthalmic composition aimed at lowering intraocular pressure. This innovative composition includes latanoprost, polyoxyl 40 hydrogenated castor oil, and sorbitol. His work in this area demonstrates a commitment to improving eye health and patient outcomes.

Career Highlights

Currently, Youn Jae Shin is associated with Taejoon Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His expertise in ophthalmic formulations has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Youn Jae Shin collaborates with talented colleagues, including Joon Youb Lee and Min Ji Lee. Their combined efforts contribute to the innovative projects at Taejoon Pharmaceutical Co., Ltd.

Conclusion

Youn Jae Shin's work in ophthalmic compositions showcases his dedication to innovation in healthcare. His contributions are vital for advancing treatments that enhance the quality of life for patients with eye conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…